Skip to Main Content

Paper Details

Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancer.
J Exp Med
41
2019
HNSCC, PGE2, PIK3CA, PIK3CA-altered, head and neck cancer, head and neck squamous cell carcinoma, oncogene, patient, patients
Author NameAffiliation
Julie E BaumanUniversity of Arizona
Hua LiUniversity of California san francisco
Neil E BholaUniversity of California san francisco
Yan ZengUniversity of California san francisco
Toni M BrandUniversity of California san francisco
Mi-Ok KimUniversity of California san francisco
Scott R VandenBergUniversity of California san francisco
Scott R VandenBergUniversity of California san francisco
Victor OlivasUniversity of California san francisco
Trever G BivonaUniversity of California san francisco
Simion I ChioseaUniversity of Pittsburgh School of Medicine
Lin WangUniversity of Pittsburgh School of Medicine
Gordon B MillsUniversity of Texas MD Anderson Cancer Center
Gordon B MillsUniversity of Texas MD Anderson Cancer Center
Umamaheswar DuvvuriUniversity of Pittsburgh School of Medicine
Patrick K HaUniversity of California san francisco
Daniel E JohnsonUniversity of California san francisco
Jennifer R GrandisUniversity of California san francisco
Jennifer R GrandisUniversity of California san francisco
  • 1 - 19

Datasets